Pre-Publication Project Biosciences

Climate Change and Health

EASAC has a significant tradition of interest in climate change issues across the Programmes. The Biosciences Programme published on climate change and infectious disease in 2010 and on some aspects of climate change-food systems-health in 2017.

Following discussion by the Biosciences Steering panel in 2016 and agreement by Council in 2017, a project has been initiated to examine the range of issues for climate change and human health, to discuss with European policy-makers and other stakeholders. It is intended both to clarify how to resolve current uncertainties in the evidence base and how to implement knowledge in a supportive EU health policy framework that also ensures integration of strategy across all relevant sectors.

The EASAC Working Group comprises:

  • Volker ter Meulen (Germany, co-chair)
  • Andy Haines (UK, co-chair)
  • Regula Gehrig (Switzerland)
  • Patrick Goodman (Ireland)
  • Roy Harrison (UK)
  • Markku Kulmala (Finland)
  • Zbigniew Kundzewicz (Poland)
  • Blaholsav Marsalek (Czech Republic)
  • Maria Nilsson (Sweden)
  • Martin Roosli (Switzerland)
  • Filipe Duarte Santos (Portugal)
  • Sebastian Vollmer (Germany)
  • Jaap van Dissel (The Netherlands)
  • Robin Fears (EASAC project secretariat)
  • Nina Hobbhahn (EASAC project secretariat)

EASAC welcomes contributions of written evidence to this project: please send your contributions to Contributions will be particularly welcome if received before 31 July 2018. We are particularly interested in answering the following questions relating to climate change:

  • What are the major health effects?
  • Who is vulnerable and where do they live?
  • Are there tipping points beyond which major and perhaps catastrophic effects could occur?
  • Over what time period will major effects take place?
  • How will development pathways modify effects?
  • What are the main adaptation and mitigation EU policy options (and their combination) to safeguard health? Which policies increase resilience? What are the trade-offs and synergies?
  • What are the most important health benefits of mitigation strategies in the key sectors (e.g. energy, housing, urban planning, food and agriculture)? Might there be unintended adverse consequences?
  • What are the wider economic and development consequences?
  • What are the barriers to implementation of EU policy options and how can they be overcome?
back to overview